These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13794588)

  • 1. Serum transaminase activity as an index of liver cell destruction.
    ARTURSON G; PERSSON BH
    Acta Chir Scand; 1959 Jul; 117():221-9. PubMed ID: 13794588
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of the serum glutamic pyruvic transaminase test for the evaluation of hepatic necrotropic compounds in rats.
    BALAZS T; AIRTH JM; GRICE HC
    Can J Biochem Physiol; 1962 Jan; 40():1-6. PubMed ID: 13864270
    [No Abstract]   [Full Text] [Related]  

  • 3. [The behaviour of the transaminase activity of the serum in infectious mononucleosis].
    ROBERT L; GROSSI CE
    Arch Maragliano Patol Clin; 1962 Apr; 18():267-75. PubMed ID: 14492733
    [No Abstract]   [Full Text] [Related]  

  • 4. [The practical value of serum transaminase determinations in diseases of the liver and bile ducts].
    LINDNER H
    Dtsch Med J; 1961 Jan; 12():15-23 contd. PubMed ID: 13762383
    [No Abstract]   [Full Text] [Related]  

  • 5. [The practical value of serum transaminase determinations in diseases of the liver and bile ducts].
    LINDNER HL
    Dtsch Med J; 1961 Jan; 12():33-9 concl. PubMed ID: 13762384
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of serum-transaminase activity in hepatic and gastrointestinal diseases.
    PRYSE-DAVIES J; WILKINSON JH
    Lancet; 1958 Jun; 1(7033):1249-53. PubMed ID: 13550981
    [No Abstract]   [Full Text] [Related]  

  • 7. Transaminase and liver-function studies in infectious mononucleosis.
    ROSALKI SB; JONES TG; VERNEY AF
    Br Med J; 1960 Mar; 1(5177):929-32. PubMed ID: 14438795
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in serum glutamic oxalacetic transaminase in patients with diseases of the heart, liver or musculoskeletal systems.
    MOORE CB; BIRCHALL R; HORACK HM; BATSON HM
    Am J Med Sci; 1957 Nov; 234(5):528-37. PubMed ID: 13487565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of serum determination of glutamic-pyruvic transaminase in viral hepatitis].
    DELAHOUSSE J; CHASTEL F; LAGARDE B; DUFOUR P; PUJO P
    Rev Corps Sante Armees Terre Mer Air; 1961 Apr; 2():205-21. PubMed ID: 13721423
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum enzymes in blood donors. II. Hepatitis screening by determination of serum glutamic pyruvic transaminase].
    RICHTERICH R; VERREY F; STAMPFLI K
    Schweiz Med Wochenschr; 1961 Dec; 91():1430-4. PubMed ID: 14492065
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with transaminase determination in subchronic and chronic lesions of the liver parenchyma].
    BOECKER W; HEINRICH WD
    Med Klin; 1960 Jul; 55():1229-33. PubMed ID: 13801953
    [No Abstract]   [Full Text] [Related]  

  • 12. [Functional examination of the liver in cardiac insufficiency. (Considerations on dysproteinemia, serum transaminases, ammonemia and other function tests)].
    VICIU E; DULGHERU C; RUSSU M; CRISAN A; GANE N; BUSNEAG C
    Med Interna (Bucur); 1962 Jan; 14():41-55. PubMed ID: 13925770
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum transaminase in endomyocardial fibrosis.
    CAMPBELL J; SOMERS K
    Br Med J; 1960 May; 1(5185):1540-1. PubMed ID: 13807269
    [No Abstract]   [Full Text] [Related]  

  • 14. High serum transaminase levels in hemorrhagic pulmonary infarct.
    PLOTZ M; GALVEZ RP
    N Y State J Med; 1960 Jun; 60():1984-5. PubMed ID: 14433523
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum transaminase activity in x-irradiated rabbits.
    ALBAUM HG; MILCH LJ
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):595-6. PubMed ID: 13389536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Importance of serum glutamate oxalacetate transaminase in heart infarct and parenchymal diseases of the liver].
    WACHTLER SF; DONATO RA
    Dtsch Arch Klin Med; 1957; 204(3):334-46. PubMed ID: 13490123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thioctic acid in experimental liver diseases caused by selenium. Behavior of the transaminase activity and histological picture. Note II].
    SQUADRITO G; CERUSO D; SACCA A
    Policlinico Med; 1959 Dec; 66():450-7. PubMed ID: 13854922
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum glutamic oxalacetic transaminase activity as an index of liver cell injury: a preliminary report.
    WROBLEWSKI F; LADUE JS
    Ann Intern Med; 1955 Aug; 43(2):345-60. PubMed ID: 13239030
    [No Abstract]   [Full Text] [Related]  

  • 19. [The behavior of serum glutamic acid-oxalacetic acid transaminase in myopathies and neurogenic muscle atrophies].
    KAESER HE
    Dtsch Z Nervenheilkd; 1959; 179():353-62. PubMed ID: 14408360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum transaminases in amebic hepatitis and amebic abscess of the liver. (Preliminary report)].
    PAVIOT JJ; SANTHANAGOPALAN T; PAL SK
    Presse Med (1893); 1962 Apr; 70():1025-6. PubMed ID: 14484581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.